Bio.com Life Sciences News Update
June 12, 2002
Produced by Bio Online(r)
Portal to the Life Sciences(tm)
www.bio.com | www.bioprotocol.com
===========================================================================
CONTENTS:
===========================================================================
1. Science News: "Evolutionary Success After Mass Extinctions"
2. InFocus: "Getting Virtual, Getting Real" - listen to the audio webcast
3. Career Center: The "Next Generation" Career Center is here
4. Jobs of the Week: "Research Associate in Discovery" and others
5. Featured Employer: Onyx Pharmaceuticals
6. Market Research: "Advertising to Life Scientists"
7. Featured Software: "BrainMaker Professional" and others
8. Featured Company: BIOTECH Magazine
===========================================================================
Newsletter Sponsored by: IBC USA Conferences
===========================================================================
IBC's Drug Discovery Technology(tm) 2002:
The World's Drug Discovery Meeting Place
August 4-9, 2002 * The Hynes Convention Center * Boston, MA
Your opportunity to learn the latest in drug discovery and
network with 5,000+ leaders in the field.
For more information:
http://www.drugdisc.com/?source=us2-180
**To receive a 10% discount for the Drug Discovery Technology 2002
conference, click here:
http://www.bio.com/ibcdd.html
===========================================================================
1. SCIENCE NEWS
===========================================================================
-Probing Cartilage on a Nanoscale
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=1
The molecular "bristles" key to cartilage function are revealing new secrets
thanks to novel nanoscale mechanical measurements by MIT researchers that
will also help characterize other components of the tissue that cushions our
joints. Understanding cartilage function-and disfunction-on a molecular
level could lead to cures for diseases such as osteoarthritis and techniques
for repairing cartilage damaged in accidents.
-Probable Causes of Hybrid Plant Vigor
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=2
Agricultural breeders have long observed that when plants or animals from
different strains are interbred, the offspring tend to be stronger,
healthier or generally more fit than either of their parents, although no
one knew why this occurred. Now plant geneticists investigating the maize
(corn) genome at Rutgers' Waksman Institute of Microbiology have discovered
a possible explanation for this phenomenon, known as heterosis or hybrid
vigor.
-Targeting Toxins to Tumor Blood Vessels
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=3
Researchers at The University of Texas M. D. Anderson Cancer Center in
Houston and The University of Texas Southwestern Medical Center at Dallas
have demonstrated in mice that a new drug formed by linking a vascular
endothelial growth factor to a toxin will target and destroy the blood
vessels supplying a malignant tumor.
-Evolutionary Success After Mass Extinctions
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=4
A significant number of organisms that survived the five greatest mass
extinctions in Earth's history subsequently failed to achieve evolutionary
success, according to a new study published by the University of Chicago's
David Jablonski.
-Brain Scan Predicts Antidepressant Response
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=5
A new UCLA Neuropsychiatric Institute study shows for the first time that
measurable changes in the front of the brain can predict the effectiveness
of an antidepressant within days of treatment - weeks before a patient
begins to feel better.
-FEATURE: Heterocyst or Not Heterocyst?
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=6
What is it in a cell that drives it to become one type of cell rather than
another? Or for that matter, what is it in a cell that summons it not to
budge? It is the fascinating world of cell fate, one of the most intriguing
questions developmental biologists have been asking themselves for centuries
now. The blue-green algae cyanobacteria Anabaena is a perfect illustration
of one model which has been on the scene for some time.
To view Industry news, visit:
http://www.bio.com/industryanalysis/industryanalysis_news.jhtml
To view Research news, visit:
http://www.bio.com/newsfeatures/newsfeatures_research.jhtml
===========================================================================
2. INFOCUS WEBCAST
===========================================================================
1) "Drug Discovery: Getting Virtual, Getting Real"
Broadcast Friday, June 7, 2002
*Click here to listen to the audio recording:
http://chat.bio.com:8000/audio/virtual_060702.mp3
*Click here to enter a drawing for a giveaway from our sponsors:
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=7
*To view all past InFocus Webcast recordings and transcripts, go to:
http://www.bio.com/newsfeatures/newsfeatures_fochives.jhtml
===========================================================================
3. CAREER CENTER
===========================================================================
Bio.com announces the "Next Generation" Career Center!
-Over 1,800 biotechnology positions at your fingertips
-New features available making your job search more powerful than ever
Visit us today to set up your FREE personal profile:
http://www.bio.com/careercenter/seekers/index.jhtml
===========================================================================
4. JOBS OF THE WEEK
===========================================================================
Look at what's new in the Bio.com Career Center this week:
1. CV Therapeutics: Associate/Senior Associate, Quality Assurance
http://www.bio.com/careercenter/seekers/view_job.jhtml?id=7000007
2. Setren Smallberg & Assoc.: Research Associate in Discovery
http://www.bio.com/careercenter/seekers/view_job.jhtml?id=6900001
3. Celera Diagnostics (Setren Smallberg & Assoc): Oligo Senior Manager
http://www.bio.com/careercenter/seekers/view_job.jhtml?id=7200002
4. Illex Oncology: Medical Writer
http://www.bio.com/careercenter/seekers/view_job.jhtml?id=5500002
5. Onyx Pharmaceuticals: Clinical/Preclinical Development Associate
http://www.bio.com/careercenter/seekers/view_job.jhtml?id=5200004
6. XenoPort: Research Associate
http://www.bio.com/careercenter/seekers/view_job.jhtml?id=6800008
Register today and start using our new features:
http://www.bio.com/careercenter/seekers/index.jhtml
Click here to browse all jobs from Bio.com's Career Center:
http://www.bio.com/careercenter/seekers/jobs_by_employer.jhtml
===========================================================================
5. FEATURED EMPLOYER
===========================================================================
Onyx Pharmaceuticals (NASDAQ: ONXX), is building a biopharmaceutical company
that changes the way cancer is treated. Our scientists engineer innovative
cancer treatments based on therapeutic adenoviruses. These agents multiply
in malignant cells, destroy them, and spread to neighboring cancer cells
with little or no apparent harm to normal tissue. ONYX-015 has advanced to
Phase III clinical status since entering the clinic in 1996. For current
openings:
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=8
===========================================================================
6. MARKET RESEARCH
===========================================================================
Bio.com offers the most comprehensive collection of market research.
-Microsystems & Nanotechnology in the Medical & Biomedical Market
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=9
Nanotechnology and Microtechnology are engineering on an extremely small
scale. Already they are being applied to create many new medical products
for drug delivery, drug screening, diagnostics, patient monitoring and
minimally invasive surgery. A new Report, published by TFI, will provide you
with essential roadmaps so that you can find your way to improving existing
products or creating innovative new products using these technologies. You
will then be able to participate fully in the growth of a new market that is
already worth $5 Billion and is projected to grow to $11 Billion in the next
3 years.
-Tachykinins Receptor Antagonists: One Therapeutic Class for Multiple
Indications?
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=10
The tachykinins were first identified in 1931 however the therapeutic
potential of their receptor antagonists is only starting to be realized.
Tachykinin receptor antagonists have been strongly implicated for the
treatment of at least 6 major disease groups including CNS disorders, pain,
airway disease, urinary incontinence, emesis and intestinal disfunction.
This document from LeadDiscovery is designed to be a key reference point for
researchers seeking new targets for a wide variety of indications or for
researchers who are already involved in the development of tachykinin
receptor antagonists but who are looking to optimize drug development
potential.
-Advertising to Life Scientists
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=11
Today, the decision as to which publications will provide the greatest
return on investment is becoming increasingly difficult due to the
proliferation of specialized scientific journals, magazines and newspapers.
Based on a 32-question survey of more than 1,100 life scientists,
Advertising to Life Scientists from BioInformatics, LLC is designed to help
marketers evaluate print advertising opportunities in leading life science
publications. The high cost of print advertising demands that special
attention be placed on the selection of the publications (and specific
issues) in which your ad is to appear.
Click here to browse through our publications catalogue:
http://www.bio.com/store/store_publications.jhtml
===========================================================================
7. FEATURED SOFTWARE
===========================================================================
Bio.com offers a very comprehensive selection of Life Science related
software. Check out these latest additions:
-BrainMaker Professional
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=12
BrainMaker Professional slashes development time, reduces trial-and-error
tedium, and creates networks that recognize patterns and predict better than
any other neural network system. Professional has all the features and ease
of use of standard BrainMaker plus the most advanced features available.
BrainMaker Professional v3 is the Advanced Neural Network Application
Development System for people who demand the most highly powered development
tools, most analysis functions, and greatest ease of use.
-ChemSite Pro
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=13
Computer-Aided Chemistry Modeling Set
Build ANY Structure Quickly! ChemSite Pro is an interactive 3D molecular
graphics environment that empowers the chemist to build, study, and present
molecules in an impressive visual environment. The intuitive Windows
interface makes ChemSite Pro easy to learn and use. Interactive 3D modeling
and real time animation lets you use molecular building blocks or atom by
atom construction to visualize even the most complex structures. Easily
build protein, DNA, organic, and inorganic molecules as fully realized,
space-filling entities. Easily build molecules by sketching them as you
would on paper and then automatically convert the sketch to an accurate 3D
model
-HyperChem Release 7 for Windows CD-ROM Plus Boxed Book Set
http://www.bio.com/Redirectors/LinkRedirect6_11.jhtml?link=14
HyperChem is a sophisticated molecular modeling environment that is known
for its quality, flexibility, and ease of use. HyperChem Release 7
incorporates even more powerful computational chemistry tools than ever
before, as well as newly incorporated modules, additional basis sets, new
drawing capabilities and more!
Click here to browse through our software catalogue:
http://www.bio.com/store/store_software.jhtml
===========================================================================
8. FEATURED COMPANY
===========================================================================
BIOTECH Magazine
BIOTECH is a full-colour magazine about the business and science of
biotechnology. It is a visually stunning publication aimed at
executives and senior scientific personnel. Examining breakthrough
developments in the science of biotechnology accompanied by
authoritative advice about funding issues, intellectual property
strategies, the regulatory environment, ethical challenges, and much
more, the magazine is a "must read" for all those interested in the
rapidly evolving life sciences. For more information:
http://biotech-magazine.com/
===========================================================================
This message is sent to <qsar_society(~)accelrys.com> per your request
To unsubscribe, simply hit Reply from this email account <qsar_society~~accelrys.com>
and put the word 'unsubscribe' in the subject field.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Copyright (c) 2002 Bio Online, Inc. All rights reserved.
Received on 2002-06-12 - 05:17 GMT
This archive was generated by hypermail 2.2.0 : 2005-11-24 - 10:21 GMT